Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
The French National Humanitarian Conference
02/23/2016. What will be the role of international humanitarian actors in the aid system of the future?
Five rare humanitarian success stories of 2016 (plus caveats)
12/29/2016. It’s hard to see the silver lining around a year as awful as 2016, but a few good news stories did emerge.
“Massive scaling up urgently needed to tackle hunger crisis” says ICRC’s Director of Operations
03/22/2017. The ICRC is appealing for $400m to help those most affected by the humanitarian crises in Somalia, Yemen, South Sudan and north-east Nigeria
